Switch to:
PDL BioPharma Inc (NAS:PDLI)
Additional Paid-In Capital
$-119.9 Mil (As of Dec. 2014)

PDL BioPharma Inc's quarterly additional paid-in capital increased from Jun. 2014 ($-120.6 Mil) to Sep. 2014 ($-120.2 Mil) and increased from Sep. 2014 ($-120.2 Mil) to Dec. 2014 ($-119.9 Mil).

PDL BioPharma Inc's annual additional paid-in capital increased from Dec. 2012 ($-234.1 Mil) to Dec. 2013 ($-233.2 Mil) and increased from Dec. 2013 ($-233.2 Mil) to Dec. 2014 ($-119.9 Mil).


Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

PDL BioPharma Inc Annual Data

AdditionalPaidInCapital 969.11,037.81,098.3169.2-83.9-87.4-161.8-234.1-233.2-119.9

PDL BioPharma Inc Quarterly Data

AdditionalPaidInCapital -234.4-234.1-233.9-233.7-233.5-233.2-121.0-120.6-120.2-119.9
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial